ت:    25332330
نقال: 90094424
2:00 الى 6:00 مساءا (أيام الإسبوع)
السبت 10:30 ص-1:30 م. الجمعة عطلة

NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins

08/10/2020

The study is taking place in hospitalized adults in the United States, Mexico and 16 other countries.

Read More